Skip to main content
  • 928 Accesses

Abstract

The scleroderma group of diseases are all characterized by the presence of hard skin. One classification of the various forms of scleroderma is listed in Table 6.1. Successful treatment of these disorders has lagged behind that of many of the other rheumatic diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Artlett CM. Immunology of systemic sclerosis. Front Biosci. 2005;10:1707–1719.

    Article  PubMed  CAS  Google Scholar 

  2. Jimenez SA, Artlett CM. Microchimerism and systemic sclerosis. Curr Opin Rheumatol. 2005;17:86–90.

    Article  PubMed  Google Scholar 

  3. Mayes MD, Lacey JV Jr, Beebe-Dimmer J et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 2003;48:2246–2255.

    Article  PubMed  Google Scholar 

  4. Duffy CM, Laxer RM, Lee P et al. Raynaud’s syndrome in childhood. J Pediatr. 1989;114:73–78.

    Article  PubMed  CAS  Google Scholar 

  5. Furst DE, Clements PJ, Steen VD et al. The modified Rodnan skin score is an accurate reflection of skin biopsy thickness in systemic sclerosis. J Rheumatol. 1998;25:84–88.

    PubMed  CAS  Google Scholar 

  6. Seely JM, Jones LT, Wallace C et al. Systemic sclerosis: using highresolution CT to detect lung disease in children. AJR Am J Roentgenol. 1998;170:691–697.

    PubMed  CAS  Google Scholar 

  7. Foeldvari I, Zhavania M, Birdi N et al. Favourable outcome in 135 children with juvenile systemic sclerosis: results of a multi-national survey. Rheumatology (Oxford). 2000;39:556–559.

    Article  CAS  Google Scholar 

  8. Zulian F. Scleroderma in children. Pediatr Clin North Am. 2005;52:521–545.

    Article  PubMed  Google Scholar 

  9. Martini A, Maccario R, Ravelli A et al. Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis. Arthritis Rheum. 1999;42:807–811.

    Article  PubMed  CAS  Google Scholar 

  10. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum. 1980; 23:581–590.

    Article  Google Scholar 

  11. Zulian F et al. Arthritis Rheum. In Press.

    Google Scholar 

  12. Murray KJ, Laxer RM. Scleroderma in children and adolescents. Rheum Dis Clin North Am. 2002;28:603–624.

    Article  PubMed  Google Scholar 

  13. Cunningham BB, Landells ID, Langman C et al. Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol. 1998;39:211–215.

    Article  PubMed  CAS  Google Scholar 

  14. Uziel Y, Feldman BM, Krafchik BR et al. Methotrexate and corticosteroid therapy for pediatric localized scleroderma. J Pediatr. 2000;136:91–95.

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer-Verlag London Limited

About this chapter

Cite this chapter

(2007). Scleroderma. In: Pediatric Rheumatology in Clinical Practice. Springer, London. https://doi.org/10.1007/978-1-84628-421-2_6

Download citation

  • DOI: https://doi.org/10.1007/978-1-84628-421-2_6

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84628-420-5

  • Online ISBN: 978-1-84628-421-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics